Antabio CEO Says M&A Is His ‘Exit Strategy’

‘Broken’ AMR Model Leaves Antibiotics Maker No Other Choice

 
• By Sten Stovall
  
Antibiotics
Clinical-Stage Antabio develops novel antibacterial treatments • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip